These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 220823

  • 1. [Pathogenetic therapy of nervous system and muscular diseases using large doses of prednisolone on alternate days].
    Gekht BM, Kuzin MI, Kolomenskaia EA, Gnezditskaia EV, Zefirova GS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):286-90. PubMed ID: 220823
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and adverse effects of using large doses of corticosteroid preparations administered every other day].
    Kolomenskaia EA, Andreeva II, Ibragimova GV, Odintsova TA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(4):531-6. PubMed ID: 6305069
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W.
    Med Welt; 1969 Nov 29; 48():2636-49. PubMed ID: 4318400
    [No Abstract] [Full Text] [Related]

  • 4. [Strategy for using glucocorticoid preparations in neuromuscular diseases].
    Gekht BM, Kolomenskaia EA, Shagal DI, Merkulova DM, Ibragimova GV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Nov 29; 85(11):1651-8. PubMed ID: 3002079
    [Abstract] [Full Text] [Related]

  • 5. [Steroid therapy for neurologic diseases--indications and methods of administration].
    Takatsu M, Toyokura Y.
    Nihon Rinsho; 1979 Jun 10; 37(6):1308-15. PubMed ID: 225590
    [No Abstract] [Full Text] [Related]

  • 6. [Experiences with intrathecal corticosteroid treatment of polysclerosis and other neurological diseases].
    Schmidt E.
    Psychiatr Neurol Med Psychol (Leipz); 1967 Apr 10; 19(4):152-6. PubMed ID: 6072684
    [No Abstract] [Full Text] [Related]

  • 7. [Principles and limits of ACTH-cortisone therapy in neurology].
    Bammer HG.
    Bibl Psychiatr Neurol; 1969 Apr 10; 139():36-59. PubMed ID: 4332888
    [No Abstract] [Full Text] [Related]

  • 8. Pathogenetic therapy of diseases of the nervous system and muscles with large doses of prednisolone on alternate days.
    Gekht BM, Kuzin MI, Kolomenskaya EA, Gnezditskaya EV, Zefirova GS, Ibragimova GV, Ippolitov IK, Kuralesin MG, Polykovskaya ID, Shagal DI.
    Neurosci Behav Physiol; 1981 Apr 10; 11(4):363-6. PubMed ID: 7343875
    [No Abstract] [Full Text] [Related]

  • 9. [Corticoid and ACTH therapy of neurologic diseases].
    Hallen O.
    Med Welt; 1973 Jun 08; 24(23):951-4. PubMed ID: 4355430
    [No Abstract] [Full Text] [Related]

  • 10. Effect of alternate-day prednisolone administration on hypophyseal-adrenocortical activity in dogs.
    Brockus CW, Dillon AR, Kemppainen RJ.
    Am J Vet Res; 1999 Jun 08; 60(6):698-702. PubMed ID: 10376895
    [Abstract] [Full Text] [Related]

  • 11. Steroids in neurology.
    Wiles CM.
    Br J Hosp Med; 1982 Oct 08; 28(4):308, 313-6, 321-2. PubMed ID: 7139155
    [No Abstract] [Full Text] [Related]

  • 12. [Immunodepressive agents in neurology].
    Sabouraud O.
    Rev Prat; 1986 Jan 21; 36(5):229-36. PubMed ID: 2870559
    [No Abstract] [Full Text] [Related]

  • 13. [Immunosuppressive therapy of various autoimmune diseases of the nervous system].
    Neretin VIa, Odinokova VA, Kir'iakov VA, Sapfirova VA.
    Sov Med; 1990 Jan 21; (12):31-5. PubMed ID: 2097756
    [No Abstract] [Full Text] [Related]

  • 14. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
    Arthritis Rheum; 2003 Jun 21; 48(6):1504-12. PubMed ID: 12794817
    [Abstract] [Full Text] [Related]

  • 15. [Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone].
    Iarosh AA, Tiazhkorob AM, Prokopiv MM, Kanevskaia SA, Zhovnir IK.
    Vrach Delo; 1991 Dec 21; (12):61-3. PubMed ID: 1792777
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of alternate-day corticosteroid administration in the treatment of polymyositis].
    Uchino M, Araki S, Yoshida O, Uekawa K, Nagata J.
    Rinsho Shinkeigaku; 1983 Oct 21; 23(10):842-6. PubMed ID: 6673865
    [No Abstract] [Full Text] [Related]

  • 17. [Experiences with intrathecal glucocorticoid therapy in inflammatory neurological diseases (35 case reports)].
    Göpel W, Bertram W.
    Z Arztl Fortbild (Jena); 1971 Jan 15; 65(2):99-103. PubMed ID: 5109213
    [No Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy.
    Pranzatelli MR, Chun KY, Moxness M, Tate ED, Allison TJ.
    Pediatr Neurol; 2005 Aug 15; 33(2):121-6. PubMed ID: 16087057
    [Abstract] [Full Text] [Related]

  • 19. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ, Young EA, Andrew R, Seckl JR.
    Clin Endocrinol (Oxf); 2006 Jul 15; 65(1):22-6. PubMed ID: 16817814
    [Abstract] [Full Text] [Related]

  • 20. Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.
    Hashimoto K, Suemaru S, Takao T, Sugawara M, Hattori T, Kageyama J, Takahashi K, Ota Z.
    J Clin Invest; 1988 Jul 15; 82(1):13-6. PubMed ID: 2839544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.